Monograph Details
|
|
Cardiovascular System
> Angina
|
|
DILACOR XR |
| Manufacturer |
|
Watson Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Calcium channel blocker (benzothiazepine). |
| Generic Name |
|
Diltiazem HCl 120mg, 180mg, 240mg; ext-rel caps. |
| Indications |
|
Chronic stable angina. |
| Children |
|
Not recommended. |
| Adults |
|
Do not crush or chew. Take in AM on empty stomach. Initially 120mg once daily. Usual max 480mg once daily. May titrate over 7–14 days. |
| Contraindications |
|
Sick sinus syndrome, 2nd- or 3rd-degree AV block unless paced. Hypotension. Acute MI and pulmonary congestion documented by X-ray on admission. |
| Precautions |
|
Impaired ventricular, renal or hepatic function. Monitor hepatic function. Discontinue if persistent rash occurs. Preexisting severe gastric stricture. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Interactions |
|
Digoxin and β-blockers may lead to AV block. Monitor digoxin levels. Serum propranolol, carbamazepine levels may be increased. Potentiation with cimetidine, cyclosporine. Anesthetics may potentiate cardiac depression. Additive hypotensive effects with antihypertensives. |
| Adverse Reactions |
|
Pain, rhinitis, GI upset, dizziness, cough, bradycardia, atrial fibrillation, arthralgia, CNS effects, dyspnea. |
| How Supplied |
|
Caps—100, 500 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
